个性化营养项目对心血管代谢健康的影响:一项随机对照试验
该随机对照试验比较了个性化膳食项目(PDP)与通用膳食建议对心血管代谢健康的影响。PDP基于食物特征、个体餐后血糖和甘油三酯反应、微生物组和健康史生成个性化食物评分,通过18周应用程序实施。意向性分析(n=347)显示,PDP组甘油三酯较对照组显著降低(平均差值=-0.13 mmol/L;对数转换95%CI=-0.07至-0.01,P=0.016),低密度脂蛋白胆固醇变化不显著。
要点
- PDP组甘油三酯较对照组显著降低(平均差值=-0.13 mmol/L;95%CI=-0.07至-0.01,P=0.016)。
- 低密度脂蛋白胆固醇变化不显著。
- 体重、腰围、HbA1c、饮食质量和微生物组β多样性等次要结局有改善(P<0.05)。
核心结论
- 与标准膳食建议相比,遵循个性化膳食在心血管代谢健康方面带来一些改善。
研究设计与样本
- 随机对照试验,参与者(n=347)年龄41-70岁,一般代表美国平均人群,随机分配至PDP组(n=177)或对照组(n=170)。
- PDP利用食物特征、个体餐后血糖和甘油三酯反应、微生物组和健康史,在18周应用程序项目中生成个性化食物评分;对照组接受基于美国农业部《2020-2025年美国居民膳食指南》的标准膳食建议,通过在线资源、签到、视频课程和传单实施。
- 主要结局为基线和18周时血清低密度脂蛋白胆固醇和甘油三酯浓度。
主要发现
- 意向性分析(n=347)显示组间甘油三酯显著降低(平均差值=-0.13 mmol/L;对数转换95%CI=-0.07至-0.01,P=0.016)。
- 低密度脂蛋白胆固醇变化不显著。
- 次要结局包括体重、腰围、HbA1c、饮食质量和微生物组β多样性有改善(P<0.05),尤其在PDP依从性高的参与者中。
- 血压、胰岛素、血糖、C肽、载脂蛋白A1和B以及餐后甘油三酯在组间无差异。
- 未报告与干预相关的严重不良事件。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Large variability exists in people's responses to foods. However, the efficacy of personalized dietary advice for health remains understudied. We compared a personalized dietary program (PDP) versus general advice (control) on cardiometabolic health using a randomized clinical trial. The PDP used food characteristics, individual postprandial glucose and triglyceride (TG) responses to foods, microbiomes and health history, to produce personalized food scores in an 18-week app-based program. The control group received standard care dietary advice (US Department of Agriculture Guidelines for Americans, 2020-2025) using online resources, check-ins, video lessons and a leaflet. Primary outcomes were serum low-density lipoprotein cholesterol and TG concentrations at baseline and at 18 weeks. Participants (n = 347), aged 41-70 years and generally representative of the average US population, were randomized to the PDP (n = 177) or control (n = 170). Intention-to-treat analysis (n = 347) between groups showed significant reduction in TGs (mean difference = -0.13 mmol l-1; log-transformed 95% confidence interval = -0.07 to -0.01, P = 0.016). Changes in low-density lipoprotein cholesterol were not significant. There were improvements in secondary outcomes, including body weight, waist circumference, HbA1c, diet quality and microbiome (beta-diversity) (P < 0.05), particularly in highly adherent PDP participants. However, blood pressure, insulin, glucose, C-peptide, apolipoprotein A1 and B, and postprandial TGs did not differ between groups. No serious intervention-related adverse events were reported. Following a personalized diet led to some improvements in cardiometabolic health compared to standard dietary advice. ClinicalTrials.gov registration: NCT05273268 .
引用
- Bermingham KM, Linenberg I, Polidori L, et al. Effects of a personalized nutrition program on cardiometabolic health: a randomized controlled trial. Nat Med. 2024. PMID: 38714898. doi:10.1038/s41591-024-02951-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。